Quantcast

CareFusion Launches Comprehensive Line of Micro-Laparoscopic Instruments

June 18, 2014

MicroLap Line Helps Achieve Virtually Scar-less Surgeries

SAN DIEGO, June 18, 2014 /PRNewswire/ — CareFusion (NYSE:CFN), a leading global medical technology company, today announced the commercial launch of its new micro-laparoscopic line of surgical instruments, one of the most comprehensive lines available in the industry.

The CareFusion MicroLap offering is a reusable platform featuring a full line of hand instruments, access devices, scopes and accessories. With instruments as small as 2.7mm in diameter, these instruments leave an incision scar that is half that of standard (5mm or 10mm) laparoscopic instruments, eliminating the need to close the incision site with sutures in some procedures and resulting in a virtually scar-less procedure.

“With the trend of miniaturizing surgical procedures, the CareFusion MicroLap line of instruments offers the advantages of smaller incisions with high-quality instrument performance,” said Andreas Lex, vice president and general manager for V. Mueller(®) and Snowden-Pencer(®) surgical instruments for CareFusion. “Smaller incisions provide the benefit of less patient discomfort and less scarring than with traditional 5mm or 10mm laparoscopic procedures.”

The hand instrument offering consists of graspers, dissectors, scissors and needle holders. Hand instrumentation is made of a proprietary ceramic titanium alloy material to provide strength comparable to standard 5mm laparoscopic instruments. Scopes are available in 2.7mm and 2.9mm diameter options, with varying lens angles available. Also included in the line are electrosurgical options as well as suction and irrigation tools.

This full line enables surgeons to use the CareFusion MicroLap line for any type of laparoscopic surgery, with no limitations on specialty or procedural uses. It also offers a wide variety of jaw patterns and handle types, so surgeons don’t have to compromise choice when switching to the CareFusion MicroLap line.

The new line of microlap instruments is manufactured by a Gimmi GmbH and CareFusion is the sole U.S. distributor.

About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris(®) infusion pumps and IV sets, MaxPlus(®) and MaxZero((TM)) IV connectors and sets, Pyxis(®) automated dispensing and patient identification systems, AVEA(®), LTV(®) series and AirLife(® )ventilation and respiratory products, ChloraPrep(®) products, MedMined(®) services for data mining surveillance, V. Mueller(®) surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs approximately 15,000 people across its global operations. More information may be found at www.carefusion.com.

http://photos.prnewswire.com/prnvar/20100706/CAREFUSIONLOGO

Logo – http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO

SOURCE CareFusion


Source: PR Newswire



comments powered by Disqus